University of Maryland Baltimore: Silver Spring Woman Becomes First Adult Sickle Cell Disease Patient in Maryland to Receive FDA-Approved Gene Therapy
May 01, 2026
May 01, 2026
BALTIMORE, Maryland, May 1 -- The University of Maryland Baltimore campus issued the following news:
* * *
Silver Spring Woman Becomes First Adult Sickle Cell Disease Patient in Maryland to Receive FDA-Approved Gene Therapy
Karen Warmkessel
Jessica Ceja, a patient liaison at a Washington, D.C. hospital, received the cells by infusion on April 27. She is the first adult patient with sickle cell anemia in Maryland to receive the gene therapy, cal . . .
* * *
Silver Spring Woman Becomes First Adult Sickle Cell Disease Patient in Maryland to Receive FDA-Approved Gene Therapy
Karen Warmkessel
Jessica Ceja, a patient liaison at a Washington, D.C. hospital, received the cells by infusion on April 27. She is the first adult patient with sickle cell anemia in Maryland to receive the gene therapy, cal . . .